Research Paper Volume 15, Issue 15 pp 7811—7830
A novel and robust pyroptosis-related prognostic signature predicts prognosis and response to immunotherapy in esophageal squamous cell carcinoma
Figure 5. Validation of the risk model in the TCGA cohort. (A) Distribution of patients in the TCGA cohort based on the median risk score in the GEO cohort. (B) The survival status for each patient. (C) PCA plot. (D) Kaplan-Meier curves for the OS of patients in the high- and low-risk groups. (E) Time-dependent ROC curves.